Liabilities / Assets
44th percentile
Higher debt load relative to assets than 44% of similar nonprofits.
Simmaron Research Inc.
990 • Fiscal year 2018 • EIN 45-2191464
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.02x
Liabilities / Revenue
45th percentile
Higher debt load relative to revenue than 45% of similar nonprofits.
Net Margin
28th percentile
Higher net margin than 28% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
22nd percentile
Faster asset growth than 22% of similar nonprofits.
Revenue Growth
23rd percentile
Faster revenue growth than 23% of similar nonprofits.
Balance Sheet
Assets
Down$552,671
Down $40,887 (-6.9%) from 2017
Net Assets
Down$542,395
Down $24,675 (-4.4%) from 2017
Liabilities
Down$10,276
Down $16,212 (-61%) from 2017
Revenue And Expenses
Revenue
Down$481,688
Down $58,419 (-11%) from 2017
Expenses
Up$506,363
Up $81,158 (+19%) from 2017
Net Income
Down-$24,675
Down $139,577 (-121%) from 2017
Historical Trend
Filing Detail Status
This 2018 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2018 to Dec 31, 2018
Mission and Program Overview
Mission
To conduct research on the etiology, pathogenesis, biomarkers, and treatment of myalgic encephelomyelitis (me) formerly know as chronic fatigue syndrome (cfs). Our mission statement is to scientifically redefine me/cfs.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2018 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $552,671
- Liabilities
- $10,276
- Net assets
- $542,395
- Revenue
- $481,688
- Expenses
- $506,363
- Net income
- -$24,675